A report on the growing evidence that West Africa is a manufacturing hub for amphetamine-type stimulants (ATS) and trafficking of drugs.

This guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization.

This edition is an updated version of the original EMCDDA guidelines, which contains new methods, concepts and examples of currently available drug prevention interventions and which provides a framework for carrying out an evaluation. The content has also been updated with developments in online EMCDDA drug prevention and evaluation resources.

The Canadian Drug Policy Coalition (CDPC) details their vision and insights on the drug situation in Canada, including articles by Professor David Nutt, author of “Drugs- Without the Hot Air”; Dan Gardner, author of “Future Babble”; Dan Werb, Co-Founder, International Centre for Science in Drug Policy, and more.

Thousands of activists marched for human rights & economic justice on Tuesday 24th July from the venue of the International AIDS Conference, to the White House

Stephen Lewis talks at the IDHDP reception at the AIDS 2012 Conference "Can We Get to Zero Without Drug Policy Reform?"

Chris Ford speaks at the IDHDP reception at the AIDS 2012 conference in Washington, on Can We Get to Zero Without Drug Policy Reform?

Human Rights Watch summarize HRW’s findings over five years of research on compulsory drug “treatment” centers in China, Cambodia, Vietnam, and Lao PDR.

Presentation slides from Martin Donghoe at the AIDS 2012 conference.

This session is a debate about the justice system - the perspective of HIV prevention, treatment, services available, policies that influence the availability of services, and TB co-infection control.

Presentation from Joseph Larmarange from the Centre Population and Devleopment (CEPED) at the AIDS 2012 Conference.

This session addresses the political dimensions of the Commission's recommendations as an essential ingredient for successfully using the law to scale-up effective HIV responses.

Presentation from Reuben Grannich from HIV/TB in the HIV/AIDS Department of WHO at the AIDS 2012 conference.

Presentation slides from Anisuddin Ahmed at the AIDS 2012 conference.

This document highlights the principles for a meaningful response to HIV among the world’s key affected populations.

This film features Alyona and Nga. Two people whose lives have been improved by accessing harm reduction services -- including needle exchange and methadone.

Presentation from Oleksandr Lebega from International HIV/AIDS Alliance in Ukraine at the AIDS 2012 conference.

Webcasts from the "Harm Reduction: Availability, Coverage, Expansion and Efficacy" oral abstracts sessions at the AIDS conference.

Webcast of Joanne Csete's from the Global Drug Policy Program presentation at the AIDS 2012 conference.

The chapter begins with an overview of the range of drugs taken by MSM, followed by a description of prevalence across the world (where such data exist) and a discussion of data quality. It then assesses the reasons for drug use by MSM and the harms that may be associated with such use. The final section highlights interventions to help reduce the harms associated with drug use among MSM.

This session addresses the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.

Presentation from the French National AIDS Council at the AIDS 2012 conference.

Webcasts from the "HIV, Drug-Use and Risks in Different Contexts" oral abstracts session at the AIDS 2012 conference.

This document is the Harm Reduction Roadmap for the AIDS 2012 conference in Washington DC 22 - 27 July 2012.

This is the third study on good practices in national drug policy from Global Drug Policy Program. The document highlights how the Czech Republic has kept low-threshold health services high on the drug policy agenda, engaged with civil society, invested seriously in research on the impact of drug policy, and managed the shifting political winds of public attitudes toward drugs.

This report highlights the major developments in harm reduction policy adoption and programme implementation that have occurred since 2010, enabling some assessment of global progress. It also explores several key issues for developing an integrated harm reduction response, such as building effective harm reduction services for women who inject drugs, access to harm reduction services by young people, drug use among men who have sex with men, global progress toward drug decriminalisation and sustainability of services in challenging environments.

Check out the new Drugs Meter, a new tool which allows people to get non-judgmental feedback on their drug use, including alcohol.

Rlease examines over 20 countries that have adopted some form of decriminalisation of drug possession, including some States that have only decriminalised cannabis possession. The main aim of the report is to look at the existing research to establish whether the adoption of a decriminalised policy led to significant increases in drug use - the simple answer is that it did not.

Danny Kushlink, Transform Drug Policy Foundation, Niamh Eastwood, Release, Tom Lloyd, former Chief Constable of Cambridgeshire Trevor Pearce, Director General, Serious and Organised Crime Agency give evidence to the Home Affairs Committee in relation to the inquiry into drugs.

The experience of Mexico with Federal law enforcement agencies from USA demonstrates that these forces are capable of increasing crime and violence instead of preventing it. This article attempts to call the attention of the Puerto Rican authorities to be cautious in their efforts to seek help to curtail drug related violence and gun smuggling when asking for help from the federal law enforcement agencies (Spanish).